Giraffe Bio Raises $6.4 Million in Seed Funding
Giraffe Bio, a company specializing in developing biochemical reagents to enhance mineral selectivity and recovery in existing flotation circuits, has successfully raised $6.4 million in a seed funding round. The funding round, which closed on October 14, 2026, was led by Orion Industrial Ventures. Other participants included BHP Ventures, Twynam, Air Capital, Baruch Future Ventures, and SOSV.
Leadership and Vision
The Buenos Aires-based company is led by Co-founder and CEO Alejandro Buffo Sempe, alongside Pablo Fortin Murga, who is part of the Founders' Office. Giraffe Bio aims to leverage its innovative solutions to improve efficiency within the mining sector, addressing critical challenges in mineral recovery processes.
Use of Funds
While specific plans for the newly acquired capital have not been disclosed, the funding is expected to support Giraffe Bio in further developing its technology and expanding its market reach. The investment will likely enhance the company's capabilities in optimizing flotation circuit performance, a crucial aspect of mineral processing.
Investor Confidence
This seed funding round demonstrates significant investor confidence in Giraffe Bio's potential to impact the mining industry positively. The diverse group of investors, including industry giants like BHP Ventures, indicates strong support for the company's mission to improve mineral processing efficiency.
Giraffe Bio's innovative approach to biochemical reagents positions it well to address the evolving needs of the mining sector, particularly in the context of increasing demand for efficient and sustainable mineral recovery solutions.